Today, Congressman Valadao (CA-22) and Congresswoman Debbie Dingell (MI-06), co-chairs of the House Asthma and Allergy Caucus, reintroduced a bipartisan resolution to designate May as “National Asthma and Allergy Awareness Month.”
WASHINGTON – Today, Congressman Valadao (CA-22) and Congresswoman Debbie Dingell (MI-06), co-chairs of the House Asthma and Allergy Caucus, reintroduced a bipartisan resolution to designate May as “National Asthma and Allergy Awareness Month.”
“In California’s Central Valley alone, over half a million people live with asthma and millions more suffer from seasonal or yearly allergies,” said Congressman Valadao. “As co-chair of the Congressional Asthma and Allergy Caucus, I’m proud to join Congresswoman Dingell to help educate the American people about the quality-of-life issues and dangers surrounding asthma and allergies.”
“Allergies and asthma impact Americans from every corner of the country, across age groups, sex, and race, myself included – though we know it is historically underserved communities that are impacted the most. My home state of Michigan has one of the highest prevalence rates of asthma in the country,” said Rep. Dingell. “I’m proud to designate May Asthma and Allergy Awareness Month to support increased education and efforts to improve the quality of live for Americans living with these conditions.”
“We’d like to thank Reps. Dingell and Valadao for their leadership of the Asthma and Allergy Caucus and for introducing the Asthma and Allergy Awareness Month Resolution,” said Kenneth Mendez, president and CEO of the Asthma and Allergy Foundation of America (AAFA). “On World Asthma Day, we take a moment to reflect on the fact that 10 people die each day from asthma. By raising awareness and leading policy change, the members of the Asthma and Allergy Caucus are doing the work that can save lives and improve the health of the 28 million Americans who have asthma. Given that asthma costs the U.S. $82 billion, continuing support for policies and programs that improve health outcomes for people with asthma provides a significant return on investment.”